Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: Results of a 5-year, randomized, placebo-controlled study
Osteoporosis International,  Clinical Article

Silverman SL et al. – The findings support a sustained anti-fracture effect of bazedoxifene on new vertebral fractures in postmenopausal osteoporotic women and on non-vertebral fractures in the higher-risk subgroup of women.

Methods

  • 4,216 postmenopausal women with osteoporosis enrolled
  • 2-year extension of 3-year, randomized, double-blind, placebo-controlled, phase 3 trial
  • In core study (N=7,492), subjects received bazedoxifene 20 or 40 mg/day, raloxifene 60 mg/day, or placebo
  • Raloxifene arm was discontinued after 3 years; subjects receiving bazedoxifene 40 mg were transitioned to bazedoxifene 20 mg after 4 years
  • 5-year findings reported for bazedoxifene 20 and 40/20 mg and placebo
  • Endpoints included incidence of new vertebral fractures (primary) and non-vertebral fractures, and changes in BMD and bone turnover markers

Results
  • At 5 years, the incidence of new vertebral fractures in the intent-to-treat population was significantly lower with bazedoxifene 20 mg (4.5%) and 40/20 mg (3.9%) versus placebo (6.8%; P<0.05), with relative risk reductions of 35% and 40%
  • Non-vertebral fracture incidence was similar among groups
  • In a subgroup of higher-risk women (n=1,324; femoral neck T-score ≤-3.0 and/or ≥1 moderate or severe or ≥2 mild vertebral fracture[s]), bazedoxifene 20 mg reduced non-vertebral fracture risk versus placebo (37%; P=0.06); combined data for bazedoxifene 20 and 40/20 mg reached statistical significance (34% reduction; P<0.05)
  • Bazedoxifene significantly increased BMD and reduced bone turnover versus placebo (P<0.05) and was generally safe and well tolerated

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Rheumatology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Rheumatology Articles

1 Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: A clinical observational study Rheumatology, February 11, 2014    Clinical Article

2 Methotrexate and lung disease in rheumatoid arthritis – A meta-analysis of randomized controlled trials Arthritis & Rheumatism, December 27, 2013    Evidence Based Medicine    Review Article    Clinical Article

3 Risk of malignancy in patients with giant cell arteritis and polymyalgia rheumatica: A systematic review and meta-analysis Seminars in Arthritis and Rheumatism, June 27, 2014    Evidence Based Medicine    Review Article

4 Identification of lymphoma predictors in patients with primary Sjögren's syndrome: A systematic literature review and meta-analysis Rheumatology International, June 5, 2014    Evidence Based Medicine    Review Article

5 Positron emission tomography assessment of large vessel inflammation in patients with newly diagnosed, biopsy-proven giant cell arteritis: A prospective, case-control study Annals of Rheumatic Diseases, June 25, 2014    Clinical Article

6 Ten common mistakes in the management of lupus nephritis American Journal of Kidney Diseases, January 3, 2014    Clinical Article

7 Intra articular injection with corticosteroids in patients with recent onset rheumatoid arthritis: subanalyses from the BeSt study Clinical Rheumatology, February 17, 2014    Clinical Article

8 Ten-year followup of infliximab therapy in rheumatoid arthritis patients with severe, longstanding refractory disease: a cohort study The Journal of Rheumatology, June 2, 2014    Clinical Article

9 Pregnancy in adult-onset idiopathic inflammatory myopathy: Report from a cohort of myositis patients from a single center Seminars in Arthritis and Rheumatism, June 4, 2014    Clinical Article

10 Is the risk of tumour necrosis factor inhibitor-induced lupus or lupus-like syndrome the same with monoclonal antibodies and soluble receptor? A case/non-case study in a nationwide pharmacovigilance database Rheumatology, June 12, 2014    Clinical Article

11 Reading of sacroiliac joints on plain pelvic radiographs: Agreement between clinical practice and trained central reading. Results of the DESIR-cohort Arthritis & Rheumatism, June 11, 2014    Clinical Article

12 Efficacy and safety of loxoprofen hydrogel patch versus loxoprofen tablet in patients with knee osteoarthritis: A randomized controlled non-inferiority trial Clinical Rheumatology, June 17, 2014    Clinical Article

13 Low-dose aspirin use and recurrent gout attacks Annals of Rheumatic Diseases, January 7, 2014    Clinical Article

14 Clinical efficacy of abatacept compared to adalimumab and tocilizumab in rheumatoid arthritis patients with high disease activity Clinical Rheumatology, January 15, 2014    Clinical Article

15 Ultrasonography as an additional item in the American College of Rheumatology classification of Sjogren's syndrome Rheumatology, June 16, 2014    Clinical Article

16 A systematic review of recommendations and guidelines for the management of osteoarthritis: The Chronic Osteoarthritis Management Initiative of the U.S. Bone and Joint Initiative Seminars in Arthritis and Rheumatism, December 6, 2013    Evidence Based Medicine    Review Article    Clinical Guideline    Clinical Article

17 Lifestyle interventions for acute gout Cochrane Reviews, December 10, 2013    Evidence Based Medicine    Review Article    Clinical Article

18 Efficacy and safety of rituximab in the treatment of non-renal systemic lupus erythematosus: A systematic review Seminars in Arthritis and Rheumatism, June 19, 2014    Review Article

19 The effects of an oral preparation containing hyaluronic acid (Oralvisc) on obese knee osteoarthritis patients determined by pain, function, bradykinin, leptin, inflammatory cytokines, and heavy water analyses Rheumatology International, June 6, 2014    Clinical Article

20 Rheumatology drug updates Full Text The Rheumatologist, March 19, 2014    Free full text

Indexed Journals in Rheumatology: Arthritis & Rheumatism, Annals of Rheumatic Diseases, Journal of Rheumatologymore

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close